Search Within

Population Sciences Research Program

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (106)
  2. Journal Article (71)
  3. Research Letter (9)
  4. Review (2)
  5. Book Section (1)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Bone Marrow Transplant (191)
  2. Center for Hematologic Malignancies (191)
  3. Department of Medicine (191)
  4. Hematologic Malignancies, Division of (191)
  5. Survivorship Research (172)
  6. Epidemiology and Biostatistics (134)

More Groups

People
  1. Sergio Giralt (108)
  2. Gunjan Shah (85)
  3. Michael Scordo (72)
  4. Andriy Derkach (67)
  5. Heather Landau (66)
  6. Hani Hassoun (63)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (28)
  4. 2022 (22)
  5. 2021 (20)
  6. 2020 (19)

More Years

Publications
  1. Blood (69)
  2. Clinical Lymphoma, Myeloma and Leukemia (20)
  3. Journal of Clinical Oncology (11)
  4. Leukemia and Lymphoma (8)
  5. Biology of Blood and Marrow Transplantation (7)
  6. Bone Marrow Transplantation (7)

More Publications

Publishers
  1. American Society of Hematology (73)
  2. Elsevier Inc. (30)
  3. Nature Publishing Group (15)
  4. American Society of Clinical Oncology (11)
  5. Taylor & Francis Group (8)
  6. American Association for Cancer Research (6)

More Publishers

Results (191)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Comparison of acute kidney injury in patients with relapsed or refractory multiple myeloma following CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Farzana, T.; Shaikh, A.; Latcha, S.; Gutgarts, V.; Jurgens, E. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Body mass index trajectory during triplet induction therapy: Clinical implications in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R. S.; Derkach, A.; Furberg, H.; Shekarkhand, T.; Rueda, C.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Feasibility and implementation of the ASH Research Collaborative's COVID-19 OutcomeS in Myeloma and the Impact of VaCcines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Wood, W. A.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Anderson, K. C.; Kumar, S.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of teclistamab among MajesTEC-1 eligible and ineligible population in the real-world setting for the treatment of relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Rajeeve, S.; Hashmi, H.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of granulocyte colony-stimulating factor exposure on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma
    Meeting Abstract

    Wang, A.; Shekarkhand, T.; Derkach, A.; Nemirovsky, D.; Tan, C.; Hamadeh, I.; Firestone, R.; Jurgens, E.; Miller, K.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save